The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
(10 - 33) Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
100 jobs Number of planned job creations
Announcement Date
2 May 2008
Employment effect (start)
Foreseen end date
2 May 2011
Description
Pfizer, a major pharmaceutical company, has announced the creation of 100 new full-time jobs in Cork over three years, to be located at a new research and development operation. Pfizer is to invest €190 million, with the support of Ireland's Industrial Development Agency (IDA), in the establishment of a biologics facility at Ring-askiddy, Cork. The new plant will be constructed on a site next to Pfizer's existing facility in Ring-askiddy, and will be running by the end of 2009.
The new plant will develop new types of medicines called biologics, which can be used in the treatment of cancer and diabetes. Biologics are specialised large-molecule medicines based on proteins, peptides and antibodies that primarily come from molecular biology developments. They must be manufactured in highly specialised and sophisticated processing plants.
Pfizer currently employs roughly 2,300 people in Ireland at sites in Cork and Dublin. Pfizer opened its main Ringaskiddy plant in Cork in 1972.
Sources
3 May 2008: The Irish Times
Citation
Eurofound (2008), Pfizer, Business expansion in Ireland, factsheet number 66596, European Restructuring Monitor. Dublin, https://dev.eurofound.europa.eu/restructuring-events/detail/66596.
This working paper offers a comprehensive methodological overview of the European Restructuring Monitor (ERM) databases. Even though the methodology has not changed over time, new categories have been added, and the way it has been used by researchers and policymakers...
This Eurofound research paper explores key trends in restructuring in recent years, highlighting the companies that announced the largest job losses and job gains in the EU. It builds on an analysis of company announcements recorded in Eurofound’s European Restructuring...
In 2023, thousands of workers in big tech lost their jobs. Meta, Amazon, Google, Apple, Microsoft and Salesforce had been considered to offer good and secure jobs up to this point. Giants of the information and communication technology (ICT) sector,...
In 2024, the automotive sector in the EU came to the fore in public and policy discussions. The focus was on the slowdown in electric vehicle (EV) sales, rising global competition, belated investments in new technologies, and the potential closure...
The more employee monitoring resembles surveillance – with its systematic, continuous and detailed tracking of employees' activities, behaviours or communications – the greater the potential for infringement of both privacy and data protection rights. Although the EU General Data Protection...
Since 2013, Eurofound's ERM database on restructuring-related legislation has been documenting regulatory developments in the Member States of the European Union and Norway which are explicitly or implicitly linked to anticipating and managing change. The most recent update to the...